JETEMA, Co., Ltd. (KOSDAQ:216080)

South Korea flag South Korea · Delayed Price · Currency is KRW
9,690.00
-410.00 (-4.06%)
At close: Feb 27, 2026
Market Cap352.34B +61.7%
Revenue (ttm)75.55B +16.8%
Net Income-4.36B
EPS-121.79
Shares Out36.36M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume389,691
Average Volume514,768
Open10,000.00
Previous Close10,100.00
Day's Range9,690.00 - 10,300.00
52-Week Range5,370.00 - 11,280.00
Beta1.01
RSI53.97
Earnings DateFeb 9, 2026

About JETEMA,

JETEMA, Co., Ltd., a bio venture company, engages in the research and development of medicines and medical devices. It offers clostridium botulinum toxins, fillers, lifting threads for medical treatment, elastin and collagen stimulate solution under Ecolla, and healthy skin care under vitten brand names. The company also provides skin care hyaluronic acid masks. JETEMA, Co., Ltd. was founded in 2009 and is headquartered in Wonju-si, South Korea. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 265
Stock Exchange KOSDAQ
Ticker Symbol 216080
Full Company Profile

Financial Performance

Financial Statements